Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 19, 2021
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
[ Mon, Jul 19th 2021
] - WOPRAI
Fri, July 16, 2021
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
Matthew Harrison Maintained (ADCT) at Buy with Decreased Target to $51 on, Jul 16th, 2021
Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $53 to $51 on, Jul 16th, 2021.
Matthew has made no other calls on ADCT in the last 4 months.
There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Brian Cheng of "Cantor Fitzgerald" Initiated at Buy and Held Target at $46 on, Tuesday, June 15th, 2021
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Friday, May 14th, 2021
